Outbreaks of infection and/or pyrogenic reactions in dialysis patients

Seminars in Dialysis

Volumn 13, Issue 2, 2000, Pages 92-96

  Roth, Virginia R ^a,b   Jarvis, William R ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIALYSIS FLUID;

ARTICLE; CENTRAL VENOUS CATHETERIZATION; CROSS INFECTION; EPIDEMIC; EQUIPMENT; FEVER; HUMAN; PUBLIC HEALTH SERVICE; RECYCLING; RENAL REPLACEMENT THERAPY; UNITED STATES;

CATHETERIZATION, CENTRAL VENOUS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CROSS INFECTION; DIALYSIS SOLUTIONS; DISEASE OUTBREAKS; EQUIPMENT CONTAMINATION; EQUIPMENT REUSE; FEVER; HUMANS; RENAL DIALYSIS; UNITED STATES;

EID: 0034150052     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-139x.2000.00027.x     Document Type: Article

References (16)

1. Sherris JC, Cole JJ, Scribner BH: Bacteriology of continuous-flow hemodialysis. Trans ASAIO 7:37-40, 1961
2. Scribner BH, Caner JEX, Buri R, Quinton W: The technique of continuous dialysis. Trans ASAIO 6:88-103, 1960
3. Favero MS, Peterson NJ, Boyer KM, Carson LA, Bond WW: Microbial contamination of renal dialysis machines and associated health risks. Trans ASAIO 20-A:175-183, 1974
4. Vas SI: Microbiologic aspects of chronic ambulatory peritoneal dialysis. Kidney Int 23:83-92, 1983
5. Vanherweghem JL, Tielemans C, Goldman M, Boelaert J: Infections in chronic hemodialysis patients. Semin Dial 4:240-244, 1991
6. Henderson LW, Koch KM, Dinarello CA, Shaldon S: Hemodialysis hypotension: the interleukin hypothesis. Blood Purif 1:3-8, 1983
7. Port FK, Van De Kerkhove KM, Kunkel SL, Kluger MJ: The role of dialysate in the stimulation of interleukin-1 production during clinical hemodialysis. Am J Kidney Dis 10:118-122, 1987
8. Gazenfeldt-Gazit E, Eliahou HE: Endotoxin antibodies in patients on maintenance hemodialysis. Isr J Med Sci 5:1032-1036, 1969
9. Lonnemann G, Behme TC, Lenzner B, et al.: Permeability of dialyzer membranes to TNF α-inducing substances derived from water bacteria. Kidney Int 42:61-68, 1992
10. Laude-Sharpe M, Caroff M, Simard L, Pusineri C, Kazatchkine MD, Haeffner-Cavaillon N: Introduction of IL-1 during hemodialysis: transmembrane passage of intact endotoxins (LPS). Kidney Ins 38:1089-1094, 1990
11. Tokars JI, Miller E, Alter MJ, Arduino MJ: National Surveillance of Dialysis-Associated Diseases in the United States, 1997. Atlanta, GA: Centers for Disease Control and Prevention, 1999
12. Task Force on Reuse of Dialyzers, Council on Dialysis, National Kidney Foundation: National Kidney Foundation report on dialyzer reuse. Am J Kidney Dis 30:859-871, 1997
13. Association for the Advancement of Medical Instrumentation: Reuse of Hemodialyzers. ANSI/AAMI RD47-1993. Arlington, VA, Association for the Advancement of Medical Instrumentation, 1993
14. Wing AI, Brunner FB, Brynger HO, et al.: Mortality and morbidity of reusing dialyzers: a report by the registration committee of the European Dialysis and Transplant Association. Br Med J 2:853-855, 1978
15. Held PJ, Pauly MV, Diamond L: Survival analysis of patients undergoing dialysis. JAMA 257:645-650, 1987
16. Pastan S, Bailey J: Medical progress: dialysis therapy. N Engl J Med 338:1428-1437, 1998